Summary
Datamonitor's Shire plc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Shire Pharmaceuticals (Shire) develops and markets pharmaceutical products in the four therapeutic areas of central nervous system, gastro-intestinal, human genetic therapies and general. The company primarily operates in the US and Europe. It is headquartered in Hampshire, United Kingdom and employs about 2,400 people. The company recorded revenues of $1,796.5 million during the fiscal year ended December 2006, an increase of 12.3% over 2005. The operating profit of the company was $90.9 million during fiscal year 2006, as compared to the operating loss of $175.6 million in 2005. The net profit was $56.2 million in fiscal year 2006, as compared to the net loss of $179.2 million in 2005.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available
|
